
Donibiz M 5mg/10mg Tablet
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Donepezil (5mg) + Memantine (10mg)
Overview Donibiz M 5mg/10mg Tablet
Alzex Duo 5mg/10mg tablets, a prescription medication, manage the symptoms of moderate to severe Alzheimer's disease. This treatment slows disease progression by enhancing cognitive function and memory. It achieves this by boosting levels of a neurotransmitter crucial for nerve signal transmission. Alzex Duo may be taken with or without food; however, taking it with food can minimize stomach discomfort. Consistent daily dosing is recommended for optimal blood levels. Missed doses should be taken promptly upon recollection. Complete the prescribed course, even with symptom improvement, and avoid abrupt cessation. Common side effects include nausea, vomiting, appetite loss, fatigue, and headache. Dizziness and drowsiness are also possible, so avoid driving or activities requiring alertness until the medication's effects are known. Maintain adequate hydration as diarrhea may occur. Prior to commencing treatment, inform your physician of any history of heart conditions, stomach ulcers, epilepsy, or asthma. Disclose all other medications currently in use, as interactions are possible. Notify your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Uses of Donibiz M 5mg/10mg Tablet
Senile dementia of the Alzheimer type
Major Benefits of Donibiz M 5mg/10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 5mg/10mg Donibiz M tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
Common Side effects of Donibiz M 5mg/10mg Tablet:
- Nausea
- Vomiting
- Loss of appetite
- Diarrhea
- Headache
- Dizziness
- Insomnia (difficulty in sleeping)
- Fatigue
- Muscle cramp
How to use Donibiz M 5mg/10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Donibiz M 5mg/10mg Tablet whole; do not alter its form by chewing, crushing, or breaking. While you can take it with or without food, consistency is key – administer it at the same time each day.
How Donibiz M 5mg/10mg Tablet works:
Combiflex AD tablets (5mg/10mg Donepezil/Memantine) offer dual-action therapy for Alzheimer's disease. This formulation combines a cholinesterase inhibitor (Donepezil) with an NMDA receptor antagonist (Memantine), synergistically regulating neurotransmitter levels to improve neuronal signaling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Donibiz M 5mg/10mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Donibiz M 5mg/10mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Donibiz M 5mg/10mg Tablet while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Donibiz M 5mg/10mg tablets.
KidneySAFE IF PRESCRIBED
Use of Donibiz M 5mg/10mg Tablet in individuals with kidney impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Donibiz M 5mg/10mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Donibiz M 5mg/10mg Tablet :
Should you forget a Donibiz M 5mg/10mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Donibiz M 5mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
